About this trial
This is a study to determine the effect of a novel patient-centered, reproductive planning decision support tool developed by the research team called MyPath on postpartum contraceptive decision-making among women with SUDs.
Eligibility criteria
Qualifiers
Be greater than or equal to 18 years of age.
Be pregnant with an EGA of 22 to 37 weeks at enrollment.
Plan to deliver at research site.
Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record.
Disqualifiers
Have had a fetal or neonatal death with their current pregnancy.
Be currently in jail or prison as required by court of law. Persons on probation or in residential facilities do not need to be excluded.
Have any other condition (social or medical) which, in the opinion of the Investigator, would make study participation unsafe, make study participation difficult, and/or complicate data interpretation.
PPC ONLY: Documented tubal ligation or hysterectomy procedures at time of delivery hospitalization
Trial design
Treatments tested in this trial
- MyPath Intervention
- Usual care
Treatment groups
Sponsors and collaborators
University of Pittsburgh
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator